We are live on ! Find out more
OFIX icon

Orthofix Medical

134 hedge funds and large institutions have $761M invested in Orthofix Medical in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 60 increasing their positions, 49 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

389% more call options, than puts

Call options by funds: $176K | Put options by funds: $36K

22% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 49

0.38% less ownership

Funds ownership: 97.5%97.11% (-0.38%)

5% less funds holding

Funds holding: 141134 (-7)

8% less capital invested

Capital invested by funds: $824M → $761M (-$62.4M)

37% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 19

Holders
134
Holders Change
-7
Holders Change %
-4.96%
% of All Funds
2.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
60
Reduced
49
Closed
19
Calls
$176K
Puts
$36K
Net Calls
+$140K
Net Calls Change
+$187K
Name Holding Trade Value Shares
Change
Change in
Stake
MLICM
101
Metropolitan Life Insurance Company (MetLife)
New York
$244K +$12.6K +298 +5%
DTL
102
Dynamic Technology Lab
Singapore
$239K +$251K +5,950 New
SFI
103
Susquehanna Fundamental Investments
Pennsylvania
$237K -$83.5K -1,976 -25%
ECM
104
ExodusPoint Capital Management
New York
$236K -$107K -2,521 -30%
Man Group
105
Man Group
United Kingdom
$228K -$3.76K -89 -2%
Handelsbanken Fonder
106
Handelsbanken Fonder
Sweden
$223K +$235K +5,558 New
ProShare Advisors
107
ProShare Advisors
Maryland
$218K -$5.11K -121 -2%
TRSOTSOK
108
Teachers Retirement System of the State of Kentucky
Kentucky
$217K
ASRS
109
Arizona State Retirement System
Arizona
$211K -$3.89K -92 -2%
CCIA
110
Campbell & Co Investment Adviser
Maryland
$206K +$217K +5,124 New
CMBA
111
C.M. Bidwell & Associates
Hawaii
$164K -$4.44K -105 -3%
Macquarie Group
112
Macquarie Group
Australia
$141K +$148K +3,505 New
MOACM
113
Mutual of America Capital Management
New York
$112K +$7.39K +175 +7%
AIP
114
Ameritas Investment Partners
Nebraska
$65K
Zurich Cantonal Bank
115
Zurich Cantonal Bank
Switzerland
$62K
HFS
116
Hantz Financial Services
Michigan
$53K -$1.89M -44,624 -97%
Royal Bank of Canada
117
Royal Bank of Canada
Ontario, Canada
$52K +$54.7K +1,294 +129,400%
First Eagle Investment Management
118
First Eagle Investment Management
New York
$49K +$52K +1,230 New
CP
119
Castleview Partners
Texas
$43K +$44.8K +1,060 New
PNC Financial Services Group
120
PNC Financial Services Group
Pennsylvania
$41K -$5.45K -129 -11%
AS
121
Altshuler Shaham
Israel
$41K +$6.97K +165 +20%
TRCT
122
Tower Research Capital (TRC)
New York
$35K -$34.2K -810 -49%
CAPTRUST Financial Advisors
123
CAPTRUST Financial Advisors
North Carolina
$33K +$211 +5 +0.6%
EVM
124
Eaton Vance Management
Massachusetts
$17K +$13.3K +315 +269%
VCM
125
Versant Capital Management
Arizona
$15K -$169 -4 -1%

OFIX Hedge Fund Activity: Q2 2021 in Review

134 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q2 2021, worth a combined $761M — down 7.6% from $824M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of OFIX and 12 opened new positions — a net loss of 7 holders — while 49 trimmed existing stakes and 60 added.

The largest buyer was Phocas Financial Corp, opening a new position worth an estimated $6.83M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $11.2M sold.

  • 134 institutional investors held Orthofix Medical (OFIX) as of Q2 2021, down from 141 in Q1 2021.
  • Funds reported $761M of Orthofix Medical stock for Q2 2021, down 7.6% quarter-over-quarter.
  • 12 funds opened new Orthofix Medical positions in Q2 2021 and 19 closed out, a net change of -7 holders.
  • The largest Orthofix Medical buyer in Q2 2021 was Phocas Financial Corp, an estimated $6.83M added.
  • The largest Orthofix Medical seller in Q2 2021 was Point72 Asset Management, an estimated $11.2M sold.

Based on aggregated 13F filings for Q2 2021.